These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 6100649)
1. HTLV and immunosuppression. Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649 [TBL] [Abstract][Full Text] [Related]
2. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus specific antigens. Lee TH; Coligan JE; Essex M Princess Takamatsu Symp; 1984; 15():197-203. PubMed ID: 6100639 [TBL] [Abstract][Full Text] [Related]
4. HTLV-III infection in homosexuals and hemophiliacs in Sweden. Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693 [TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs. Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696 [TBL] [Abstract][Full Text] [Related]
6. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives. Ohtsu T; Tsugane S; Tobinai K; Shimoyama M; Nanri S; Watanabe S Jpn J Cancer Res; 1987 Dec; 78(12):1347-53. PubMed ID: 2892821 [TBL] [Abstract][Full Text] [Related]
8. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related]
9. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
11. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [TBL] [Abstract][Full Text] [Related]
12. Structural and epidemiological features of primate lymphotropic retroviruses. Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632 [TBL] [Abstract][Full Text] [Related]
13. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia. Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253 [TBL] [Abstract][Full Text] [Related]
14. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological findings in HTLV-III infection. Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694 [TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa. Clark JW; Robert-Guroff M; Ikehara O; Henzan E; Blattner WA Cancer Res; 1985 Jun; 45(6):2849-52. PubMed ID: 2985255 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346 [TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression. Shaw GM; Broder S; Essex M; Gallo RC Adv Intern Med; 1984; 30():1-27. PubMed ID: 6084947 [TBL] [Abstract][Full Text] [Related]
19. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses. Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635 [TBL] [Abstract][Full Text] [Related]
20. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III). Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]